Insmed Incorporated (INSM)
NASDAQ: INSM · IEX Real-Time Price · USD
64.50
-1.84 (-2.77%)
At close: Jul 2, 2024, 4:00 PM
64.45
-0.05 (-0.08%)
After-hours: Jul 2, 2024, 7:31 PM EDT
Insmed Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for Insmed stock have an average target of 68.13, with a low estimate of 42 and a high estimate of 88. The average target predicts an increase of 5.63% from the current stock price of 64.50.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Insmed stock from 16 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 5 | 9 | 9 | 9 |
Buy | 5 | 5 | 7 | 7 | 7 | 7 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 9 | 9 | 12 | 16 | 16 | 16 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $70 | Strong Buy | Reiterates | $70 | +8.53% | Jul 2, 2024 |
Truist Securities | Truist Securities | Strong Buy Maintains $68 → $88 | Strong Buy | Maintains | $68 → $88 | +36.43% | Jul 1, 2024 |
B of A Securities | B of A Securities | Strong Buy Maintains $62 → $83 | Strong Buy | Maintains | $62 → $83 | +28.68% | Jun 28, 2024 |
Evercore ISI Group | Evercore ISI Group | Buy Maintains $42 → $75 | Buy | Maintains | $42 → $75 | +16.28% | Jun 21, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 20, 2024 |
Financial Forecast
Revenue This Year
360.38M
from 305.21M
Increased by 18.08%
Revenue Next Year
523.25M
from 360.38M
Increased by 45.19%
EPS This Year
-4.60
from -5.34
EPS Next Year
-3.99
from -4.60
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 389.6M | 659.8M | 1.2B | 1.9B | 2.9B |
Avg | 360.4M | 523.3M | 925.9M | 1.5B | 2.2B |
Low | 328.8M | 420.7M | 618.3M | 971.6M | 1.4B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 27.6% | 83.1% | 128.4% | 108.0% | 86.2% |
Avg | 18.1% | 45.2% | 77.0% | 66.3% | 44.0% |
Low | 7.7% | 16.7% | 18.2% | 4.9% | -9.9% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -4.07 | -3.16 | -1.42 | 1.58 | 4.29 |
Avg | -4.60 | -3.99 | -2.24 | 0.10 | 2.57 |
Low | -4.87 | -5.50 | -3.21 | -0.71 | 1.17 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | 4,285.7% |
Avg | - | - | - | - | 2,522.9% |
Low | - | - | - | - | 1,091.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.